Lauren Bullaro Riker is President & VP at Pacira Pharmaceuticals, Inc. (PCRX). They have made 28 open-market trades across 1 company since 2013, most recently 2023-07-05.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 28 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PCRX | 22,687 | $825K |
Shares reported on the most recent Form 4, priced at the 2023-07-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCRX | SELL · 10b5-1 | 2023-07-05 | 2023-07-07 | $38.91 | $25K | -2.8% | +0.8% | -23.2% |
| PCRX | SELL · 10b5-1 | 2023-06-14 | 2023-06-16 | $38.47 | $467K | -3.4% | -7.7% | -15.0% |
| PCRX | SELL | 2023-06-06 | 2023-06-07 | $38.42 | $46K | +9.4% | +1.4% | -7.0% |
| PCRX | SELL | 2022-06-06 | 2022-06-08 | $61.37 | $141K | -9.5% | -2.7% | -12.5% |
| PCRX | SELL | 2022-03-10 | 2022-03-14 | $71.22 | $662K | +6.5% | +6.9% | -23.0% |
| PCRX | SELL | 2022-01-18 | 2022-01-20 | $64.97 | $162K | -2.1% | -1.6% | +18.1% |
| PCRX | SELL | 2021-07-28 | 2021-07-30 | $60.85 | $299K | -3.3% | +0.5% | -11.4% |
| PCRX | SELL | 2021-06-11 | 2021-06-11 | $59.85 | $240K | -0.2% | -6.1% | -7.1% |
| PCRX | SELL | 2021-06-04 | 2021-06-08 | $61.04 | $128K | -1.9% | -7.4% | -7.2% |
| PCRX | SELL | 2021-03-15 | 2021-03-17 | $71.98 | $363K | +2.4% | -9.6% | -14.5% |
| PCRX | SELL | 2020-11-13 | 2020-11-17 | $63.81 | $191K | -5.8% | -6.4% | +15.5% |
| PCRX | SELL | 2020-09-16 | 2020-09-17 | $60.34 | $181K | -2.5% | -10.2% | -2.4% |
| PCRX | SELL | 2020-08-11 | 2020-08-13 | $60.50 | $495K | -0.8% | -4.3% | -2.1% |
| PCRX | SELL | 2020-06-29 | 2020-07-01 | $49.47 | $297K | -1.1% | -6.0% | +6.1% |
| PCRX | SELL | 2020-06-04 | 2020-06-08 | $47.96 | $210K | -6.4% | +18.8% | +26.3% |
| PCRX | SELL | 2020-05-19 | 2020-05-21 | $44.04 | $176K | +2.2% | +0.1% | +39.5% |
| PCRX | SELL · 10b5-1 | 2020-02-10 | 2020-02-12 | $48.81 | $146K | -6.3% | -29.0% | -13.0% |
| PCRX | SELL · 10b5-1 | 2020-02-06 | 2020-02-10 | $46.81 | $47K | -3.8% | -30.2% | -12.3% |
| PCRX | SELL · 10b5-1 | 2019-12-23 | 2019-12-26 | $45.92 | $46K | -5.7% | -3.8% | -33.4% |
| PCRX | SELL | 2019-11-20 | 2019-11-22 | $44.14 | $104K | +1.9% | +3.1% | +12.4% |
| PCRX | SELL | 2019-11-11 | 2019-11-12 | $43.59 | $436K | +4.0% | +7.0% | +16.9% |
| PCRX | SELL | 2019-06-10 | 2019-06-12 | $44.28 | $188K | -0.6% | -4.9% | -15.3% |
| PCRX | SELL | 2019-06-04 | 2019-06-06 | $42.91 | $41K | +3.1% | +1.9% | -13.9% |
| PCRX | SELL | 2018-11-02 | 2018-11-06 | $54.35 | $54K | -5.9% | -3.2% | -19.4% |
| PCRX | SELL | 2018-09-24 | 2018-09-26 | $50.70 | $51K | -7.6% | -5.9% | -10.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.